Crossmark

Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker

Crossref DOI link: https://doi.org/10.3389/fimmu.2017.02007

Published Online: 2018-01-16

Update policy: https://doi.org/10.3389/crossmark-policy

Authors

Rodríguez-Carrio, Javier

Alperi-López, Mercedes

López, Patricia

Ballina-García, Francisco J.

Suárez, Ana
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (PI12/00523, PI16/00113)

Ministerio de Economía y Competitividad (FJCI-2015-23849)
License Information

License valid from 2018-01-16